[ | E-mail ] Share Contact: Jamie Brownjamie.brown@manchester.ac.uk 44-016-127-58383University of Manchester@UoMNews Some patients with non-small cell lung cancer (NSCLC) have changes in the anaplastic lymphoma kinase (ALK) gene, which can drive the development of their cancer. A drug…
Source:More evidence for impact of lung cancer targeted therapy from practice-changing trial
Thursday, December 4, 2014
More evidence for impact of lung cancer targeted therapy from practice-changing trial
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment